Non-coding RNA in Carcinogenesis
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (20 October 2023) | Viewed by 377
Special Issue Editors
Interests: non-coding RNA; epigenetic regulation; drug resistance; breast cancer; angiogenesis; immunotherapy
Special Issue Information
Dear Colleagues,
Non-coding RNAs (ncRNAs) constitute more than 90% of the RNAs made from the human genome, but most of the known ncRNAs have been discovered only in the past ten years and remain largely unstudied. Extensive research on ncRNAs has provided new insights into the carcinogenesis of cancer. Increasing studies have demonstrated that the dysregulated expression of ncRNAs, including miRNAs，tRNA, tsRNAs, piRNAs, lncRNAs, pseudogene, circRNAs, and the interaction network between them, is a tangled process that influences cancer biological process and development. Understanding how ncRNAs drive tumorigenesis and pathogenesis is essential to improving the diagnosis, treatment, and prognosis of cancer.
In this Special Issue, we would like to shed light on the cellular and molecular pathways regulated by ncRNAs linking solid tumor development, such as breast cancer, gastric cancer, hepatocellular carcinoma, lung cancer, and so on.
To address these topics, we will welcome original research articles or state-of-the-art reviews on ncRNA and the interactions between them in various solid tumor carcinogenesis, including possible therapeutic strategies for the prevention and treatment of cancer.
Prof. Dr. Lihong Wang
Dr. Hong Fan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Non-coding RNA
- lncRNA
- circRNA
- miRNA
- carcinogenesis
- epigenetic regulation
- drug resistance
- cancer metabolism
- tumor microenvironment
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
